In an interview with touchNEUROLOGY, Prof. Heinz Reichmann (University of Dresden Medical School, Germany) gave us his insight into his highlights in Parkinson’s disease, the interventions currently under investigation and how he sees management strategies for Parkinson’s disease evolving in the coming years.
Questions:
- What are your highlights from the Parkinson’s disease scientific sessions at EAN 2022? (00:12)
- Which interventions currently under investigation are you most excited about? (00:58)
- How do you see management strategies for Parkinson’s disease evolving in the coming years? (01:25)
Disclosures: Heinz Reichmann has been a consultant for BIAL and Zambon, UCB, Neuroderm; has participated in advisory boards for BIAL, Zambon and Neuroderm; and received honoraria from BIAL, Zambon, Neuroderm, Desitin and Stadapharm.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Lisa Glass.
Filmed as a highlight of EAN 2022.
